Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette–Guérin (BCG) vaccination
Top Cited Papers
- 1 February 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 123 (2) , 219-225
- https://doi.org/10.1046/j.1365-2249.2001.01446.x
Abstract
The protective efficacy of BCG vaccination against pulmonary tuberculosis (TB) is highly variable in different populations. The reason remains to be elucidated. This study aims to investigate the possible effect of intestinal helminths on the immune response to PPD in naturally immunized or BCG-vaccinated humans. The study population was assessed for helminthic infection and those found to be positive were randomly assigned to either an albendazole treatment group or a control group who received a placebo. The immune response to PPD was compared between the two groups. In addition, subjects who were tuberculin skin test-negative in both groups were BCG vaccinated and later on tested for PPD-specific responses. Albendazole induced elimination/or reduction in intestinal worms resulting in a significant improvement in T cell proliferation and in interferon-gamma production by peripheral blood mononuclear cells (PBMC) stimulated with PPD. Moreover, BCG vaccination significantly improved PPD-specific immune responses in the treated group but not in the placebo group. The differences in the in vivo skin test responses were not significant. The data show that cellular immune responses to PPD are reduced in persons with concurrent helminthic infections, perhaps reflecting a lowered resistance to mycobacterial infections. This could explain, at least in part, the reduced efficacy of BCG against TB in helminth-endemic areas of the world.Keywords
This publication has 35 references indexed in Scilit:
- Can eradication of helminthic infections change the face of AIDS and tuberculosis?Immunology Today, 1999
- The Immune Response in Human Tuberculosis—Implications for Tuberculosis ControlThe Journal of Infectious Diseases, 1997
- Elevated Cellular Immune Responses and Interferon- Release after Long-Term Diethylcarbamazine Treatment of Patients with Human Lymphatic FilariasisThe Journal of Infectious Diseases, 1995
- Immune activation is a dominant factor in the pathogenesis of African AIDSImmunology Today, 1995
- Rapid Progression To Disease In African Sex Workers With Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1995
- Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris.The Journal of Experimental Medicine, 1995
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosisImmunology Today, 1991
- The effect of oral mycobacterium vaccae on subsequent responses of mice to BCG sensitizationTubercle, 1985
- TUBERCULIN SKIN TESTS AND B.C.G. VACCINATION IN HYPERENDEMIC AREA OF ONCHOCERCIASISThe Lancet, 1977